- Cash flow from investor perspective
- Review of key cash flow generation levers and productivity metrics
- Capital allocation to support long-term growth and value creation
- Creating a sustained mindset and behavioral shift in how cash flow generation is managed
- Improved forecasting and governance to drive greater focus and discipline of cash flow management
Amy Ellixson
Head of Cash Flow Generation Office
Johnson & Johnson
Amy is currently Head of Cash Flow Generation. In this role, Amy serves as a critical member of the Global Finance Leadership Team and together with the business is creating a best-in-class value creation culture that unlocks capital from the business allowing for reinvestment in innovation for the future. She is leading a team to improve strong free cash flow generation to support operating needs, M&A activity, dividend increases, and share repurchase programs. This team is also creating agility to promote strategic business decisions and fund growth to better support the communities we serve.
Most recently, Amy served as the Vice President, Group Finance, Supply Chain where she provided senior financial leadership and strategic counsel for the Supply Chain organization, leading a team of global finance leaders across 30 countries and driving compliance, managing a complex global portfolio and partnering end-to-end in support of our supply chain strategy to strengthen operations and deliver customer-centered growth.
Prior to that, Amy served as Vice President, Finance for the DePuy Synthes Franchise, Medical Device US Strategic Customer Group, and Medical Device Canada. She led her team to deliver innovative solutions that drove growth and increase competitiveness for the Medical Device organization. Throughout her 30-year tenure at Johnson & Johnson, Amy has held numerous roles of increasing responsibility across all three sectors of Johnson & Johnson including Vice President, Finance for North America Medical Device, as well as two consecutive Vice President, Finance roles in Supply Chain, first in Consumer Supply Chain followed by Medical Device Supply Chain.
Prior to her Supply Chain Finance roles, she served as Vice President, Finance for US OTCs, WW Nutritionals and Wellness & Prevention after four years in the Innovative Medicine sector. Additionally, she spent 15 years in the Consumer sector, where she served as the OTC Marketing and Sales Finance Director, sitting on the McNeil OTC Board.
Amy earned her MBA from St. Edwards University in Austin, Texas. She also has a Bachelor of Science in Business Administration, with a concentration in Finance and Accounting from Drexel University in Philadelphia, Pennsylvania. Amy and her husband Jim have three children, Tyler, Mckenna and Meghan.
